Benefits and risks of antiplatelet therapy for moyamoya disease: a systematic review and meta-analysis
BackgroundMoyamoya disease (MMD) is a leading cause of stroke in children and young adults, whereas no specific drugs are available. Antiplatelet therapy (APT) has been considered a promising treatment option, but its effectiveness remains controversial. Therefore, we aimed to comprehensively evalua...
Main Authors: | Tingting Liu, Mingzhen Qin, Xuejiao Xiong, Tingting Li, Luda Feng, Xinxing Lai, Ying Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2023.1132339/full |
Similar Items
-
Edaravone use in acute intracerebral hemorrhage: A systematic review and meta-analysis of randomized controlled trials
by: Mingzhen Qin, et al.
Published: (2022-08-01) -
Efficacy and safety of Panax notoginseng saponins (Xuesaitong) for patients with acute ischemic stroke: a systematic review and meta-analysis of randomized controlled trials
by: Xinyi Shi, et al.
Published: (2023-10-01) -
Potential predictors for progression of moyamoya disease: A systematic review and meta-analysis
by: Jun Cao, et al.
Published: (2023-03-01) -
Moyamoya hastalığında fonksiyonel iyileşme
by: Mehmet DURAY, et al.
Published: (2017-09-01) -
Clinical Management of Moyamoya Patients
by: Isabella Canavero, et al.
Published: (2021-08-01)